PARSED CONTENT

The web site aegeabiotech.com states the following, "NextGen Nucleic Acid Technologies for Improving Human Health." We noticed that the website stated " Selector Assays Run on any PCR Platform." It also said " Selector Amplification Powers Ultra Sensitive Molecular diagnostic Assays. Detect Rare Cancer Associated Mutations at 0. The real-time PCR market, which includes kits, fluorescent detection methods and instrumentation, is growing rapidly, and is an increasingly important segment of the total PCR market. The PCR market includes a combination of instrument, reagents, and software analysis tools." The header had Nucleic Acid Technologies as the highest ranking optimized keyword. This keyword is followed by in-vitro diagnostic markets, PCR Amplification Assay, and Selector technology which isn't as urgent as Nucleic Acid Technologies. The other words aegeabiotech.com used was Molecular Diagnostics. NextGen Sequencing is included but could not be seen by search crawlers.